NewsBenzingaThermo Fisher Scientific autoriza una recompra de acciones por 5.000 millones de dólares tras sólidos resultados trimestrales Thermo Fisher Scientific autoriza una recompra de acciones por 5.000 millones de dólares tras sólidos resultados trimestrales Benzinga 2026.11.06 15:21 (GMT+0) Open on Benzinga Other news RBC Capital Maintains Outperform on Acadia Healthcare Co, Raises Price Target to $41 Oppenheimer Maintains Outperform on EverCommerce, Lowers Price Target to $11 RBC Capital Downgrades Brookfield Business to Sector Perform, Maintains Price Target to $34 Energy Vault Japan Collaborates With PowerX To Explore Supply Of 1.5 GWh of PowerX’s Mega Power Series For Energy Vault's U.S. Projects Next Year Telehealth Giant Hims & Hers Partners with Eli Lilly for Direct Weight Loss Drug Delivery Oppenheimer Maintains Outperform on BILL Holdings, Raises Price Target to $60
Energy Vault Japan Collaborates With PowerX To Explore Supply Of 1.5 GWh of PowerX’s Mega Power Series For Energy Vault's U.S. Projects Next Year
